Plandai Biotechnology Inc (OTCMKTS:PLPL) Stock Gains Momentum: Here is Why

Leading provider of advanced disinfection solutions and a subsidiary of Plandai Biotechnology Inc (OTCMKTS:PLPL), ByoPlanet, on May 19, 2023, announced the establishment of a comprehensive one-year distribution agreement with Merck Animal Health.

Plandai Subsidiary ByoPlanet Announces Strategic Distribution Agreement with Merck Animal Health

Merck Animal Health, a global leader in animal health solutions, is responsible for distributing Merck Animal Health’s Armatrex antimicrobial solutions to the $36 billion animal health market.

The strategic collaboration between Merck Animal Health and ByoPlanet aims to harness the strengths of both companies for delivering advanced antimicrobial solutions to customers, including companion and commercial animal sectors.

Rick O’Shea, founder of ByoPlanet and CEO of Plandai Biotechnology expressed excitement about the partnership with Merck Animal Health. Shea added that joint forces with a global leader can expand offerings to the animal health market and can strengthen its position as an emerging force in the advanced disinfectant solutions market. She added that the collaboration shows a commitment to innovation and dedication to giving customers with effective products.

ByoPlanet will be responsible for the marketing and distribution of Armatrex to customers in the animal health industry. The firm’s network of industry relationships and extensive customer base will facilitate access to Armatrex for veterinarians, animal health professionals as well as other stakeholders. The company’s management believes that the collaboration will ameliorate the availability of Armatrex across the animal health market.